| mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
| mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.8 |
| mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.9 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.9 |
| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.9 |